different glp 1 Schematic representation of GLP-1 analogues previously A Tale of Two Incretins

Notably, GLP-1RA treatment increased the relative abundance of N, N-dimethyl sphingosine (DMS), an endogenous metabolite derived from sphingosine

This function of GLP-1 under an inflammatory condition shows the therapeutic possibility of GLP-1 in the depressive brain accompanied by neuroinflammation

Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population

Each pen contains one dose

[(accessed on 8 May 2024)]

Longevity of the term of usage: Phentermine is designed for only 12 weeks of use